Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Anemia as a factor related to the progression of proliferative diabetic retinopathy after photocoagulation.

Sepúlveda FJ, Pérez P, Medinilla MG, Aboytes CA.

J Diabetes Complications. 2012 Sep-Oct;26(5):454-7. doi: 10.1016/j.jdiacomp.2012.04.013. Epub 2012 May 23.

PMID:
22626876
2.

Routine, single session, indirect laser for proliferative diabetic retinopathy.

Tinley CG, Gray RH.

Eye (Lond). 2009 Sep;23(9):1819-23. doi: 10.1038/eye.2008.394. Epub 2009 Jan 9.

PMID:
19136919
3.
5.
6.
8.

[Results of pan-retinal argon laser coagulation in proliferative diabetic retinopathy].

Lüttke B, Lang GE, Böhm BO, Lang GK.

Ophthalmologe. 1996 Dec;93(6):694-8. German.

PMID:
9081526
9.
10.

Visual prognosis after panretinal photocoagulation for proliferative diabetic retinopathy.

Bek T, Erlandsen M.

Acta Ophthalmol Scand. 2006 Feb;84(1):16-20.

11.

Microalbuminuria and low hemoglobin as risk factors for the occurrence and increasing severity of diabetic retinopathy.

Ajoy Mohan VK, Nithyanandam S, Idiculla J.

Indian J Ophthalmol. 2011 May-Jun;59(3):207-10. doi: 10.4103/0301-4738.81029.

12.

Increased IL-6 levels are not related to NF-κB or HIF-1α transcription factors activity in the vitreous of proliferative diabetic retinopathy.

Arjamaa O, Pöllönen M, Kinnunen K, Ryhänen T, Kaarniranta K.

J Diabetes Complications. 2011 Nov-Dec;25(6):393-7. doi: 10.1016/j.jdiacomp.2011.06.002. Epub 2011 Aug 2.

PMID:
21813290
13.

Binocular indirect panretinal laser photocoagulation for the treatment of proliferative diabetic retinopathy.

Gurelik G, Coney JM, Zakov ZN.

Ophthalmic Surg Lasers Imaging. 2004 Mar-Apr;35(2):94-102.

PMID:
15088818
14.

Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy.

Klein R, Klein BE, Moss SE, Cruickshanks KJ.

Arch Intern Med. 1994 Oct 10;154(19):2169-78.

PMID:
7944837
15.

The relationship between hemoglobin levels and diabetic retinopathy.

Qiao Q, Keinänen-Kiukaanniemi S, Läärä E.

J Clin Epidemiol. 1997 Feb;50(2):153-8.

PMID:
9120508
16.

Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.

Lip PL, Belgore F, Blann AD, Hope-Ross MW, Gibson JM, Lip GY.

Invest Ophthalmol Vis Sci. 2000 Jul;41(8):2115-9.

PMID:
10892852
17.

Type 1 diabetes patients with severe non-proliferative retinopathy may benefit from panretinal photocoagulation.

Lövestam-Adrian M, Agardh CD, Torffvit O, Agardh E.

Acta Ophthalmol Scand. 2003 Jun;81(3):221-5.

18.

The relationship between diabetic retinopathy, glycemic control, risk factor indicators and patient education.

Axer-Siegel R, Herscovici Z, Gabbay M, Mimouni K, Weinberger D, Gabbay U.

Isr Med Assoc J. 2006 Aug;8(8):523-6.

19.

Determinants of retinopathy progression in type 1 diabetes mellitus.

Cohen RA, Hennekens CH, Christen WG, Krolewski A, Nathan DM, Peterson MJ, LaMotte F, Manson JE.

Am J Med. 1999 Jul;107(1):45-51.

PMID:
10403352
20.

[Visual stability in diabetic retinopathy treated by panretinal laser photocoagulation].

Maia OO Jr, Takahashi WY, Bonanomi MT, Marback RF, Kara-José N.

Arq Bras Endocrinol Metabol. 2007 Jun;51(4):575-80. Portuguese.

Supplemental Content

Support Center